blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3323410

EP3323410 - PHARMACEUTICAL PARENTERAL FORMULATION CONTAINING CARGLUMIC ACID [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  03.05.2019
Database last updated on 24.08.2024
FormerThe application has been published
Status updated on  20.04.2018
Most recent event   Tooltip03.05.2019Application deemed to be withdrawnpublished on 05.06.2019  [2019/23]
Applicant(s)For all designated states
RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA S.p.a.
Via Matteo Civitali, 1
20148 Milano / IT
[2018/21]
Inventor(s)01 / BERLATI, Fabio
Via Aldo Moro, 9
I-20017 Rho (MI) / IT
02 / MENEGON, Sergio
RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA S.P.A.
Via Matteo Civitali, 1
I-20148 Milano (MI) / IT
03 / FARINA, Pierluigi
RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA S.P.A.
Via Matteo Civitali, 1
I-20148 Milano (MI) / IT
04 / PROVVEDINI, Diego
RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA S.P.A.
Via Matteo Civitali, 1
I-20148 Milano (MI) / IT
05 / BARCHIELLI, Marco
RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA S.P.A.
Via Matteo Civitali, 1
I-20148 Milano (MI) / IT
06 / MATTEI, Alberto
RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA S.P.A.
Via Matteo Civitali, 1
I-20148 Milano (MI) / IT
 [2018/21]
Representative(s)Pistolesi, Roberto, et al
Dragotti & Associati Srl
Via Nino Bixio, 7
20129 Milano / IT
[2018/21]
Application number, filing date16199942.022.11.2016
[2018/21]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP3323410
Date:23.05.2018
Language:EN
[2018/21]
Search report(s)(Supplementary) European search report - dispatched on:EP04.05.2017
ClassificationIPC:A61K9/00, A61K47/18, A61K47/26, A61K9/19, A61K31/00, A61K9/08
[2018/21]
CPC:
A61K9/0019 (EP,IL,KR,US); A61K9/19 (EP,IL,KR,US); A61K31/198 (EP,IL,KR,US);
A61K47/18 (EP,IL,KR,US); A61K47/26 (EP,IL,KR,US); A61K9/08 (EP,IL,KR,US);
A61P3/00 (EP,IL,KR); A61P5/00 (EP,IL,KR); A61P7/00 (EP,IL) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2018/21]
Extension statesBANot yet paid
MENot yet paid
Validation statesMANot yet paid
MDNot yet paid
TitleGerman:PHARMAZEUTISCHE PARENTERALE FORMULIERUNG MIT CARGLUMSÄURE[2018/21]
English:PHARMACEUTICAL PARENTERAL FORMULATION CONTAINING CARGLUMIC ACID[2018/21]
French:FORMULATION PHARMACEUTIQUE PARENTÉRALE CONTENANT UN ACIDE CARGLUMIQUE[2018/21]
Examination procedure24.11.2018Application deemed to be withdrawn, date of legal effect  [2019/23]
09.01.2019Despatch of communication that the application is deemed to be withdrawn, reason: examination fee not paid in time  [2019/23]
Fees paidPenalty fee
Additional fee for renewal fee
30.11.201803   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]GB1112347  (PIERRE WIRTH) [A] 1-16* tables 1-3 *;
 [XAI]  - Jae-Ho Lee ET AL, "N-Carbamoyl- l-Glutamate Plus l-Arginine Can Protect Ammonia Intoxication in Rats with Reduced Functional Liver Mass", Biochemical and Biophysical Research Communications, UNITED STATES, doi:10.1006/bbrc.1998.8984, (19980101), pages 391 - 394, URL: http://www.sciencedirect.com/science/article/pii/S0006291X98989847/pdf?md5=4180af08dafbdefbacfd92cfb002e136&pid=1-s2.0-S0006291X98989847-main.pdf, XP055366362 [X] 1,9,11,13,16 * Experimental procedures on page 392; fig 1 * [A] 2,3,7 [I] 4-6,8,10,12,14,15

DOI:   http://dx.doi.org/10.1006/bbrc.1998.8984
by applicantEP2777696
 CN105056246
    - P. STAHL; C. WERMUTH, Handbook of pharmaceutical salts, WILEY-VCH, (2008), pages 127 - 133
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.